Outcomes of COVID-19 Infection and Vaccination Among Individuals With Myasthenia Gravis.

ABSTRACT:

Importance

There are limited data regarding COVID-19 outcomes and vaccine uptake and safety among people with myasthenia gravis (MG).

Objective

To investigate COVID-19-related outcomes and vaccine uptake among a population-based sample of adults with MG.

Design, setting, and participants

This population-based, matched cohort study in Ontario, Canada, used administrative health data from January 15, 2020, and August 31, 2021. Adults with MG were identified using a validated algorithm. Each patient was matched by age, sex, and geographic area of residence to 5 controls from the general population and from a cohort of individuals with rheumatoid arthritis (RA).

Exposure

Patients with MG and matched controls.

Main outcomes and measures

Main outcomes were COV

SUBMITTER: Alcantara M 

PROVIDER: S-EPMC10130942 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature